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effect of camptothecin appears to require DNA synthe-
sis [5–8], suggesting that it is the collision of a replication
fork with the stalled topoisomerase I that leads to cell
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Box 357742 death [9, 10]. Since Tdp1 theoretically counteracts the
effects of camptothecin and its derivatives, drugs thatUniversity of Washington
Seattle, Washington 98195 inhibit the phosphodiesterase would be predicted to act
synergistically with this class of topoisomerase poisons2 Department of Microbiology
Box 357242 and could be valuable in a combined drug therapy
regimen.School of Medicine
University of Washington It has recently been shown, based on sequence com-
parisons and on a mutational analysis of active site resi-Seattle, Washington 98195
3 Howard Hughes Medical Institute dues in human Tdp1, that the enzyme belongs to the
phospholipase D (PLD) superfamily [11]. This conclusionUniversity of Washington
Seattle, Washington 98195 is confirmed by the demonstration of a phosphoenzyme
covalent intermediate in the reaction [11]. Other mem-
bers of the PLD superfamily, besides phospholipases
D, are bacterial phosphatidyl serine, cardiolipin synthe-Summary
tases, a bacterial nuclease (Nuc) from Salmonella typhi-
murium, a bacterial toxin, and a number of poxvirusTyrosyl-DNA phosphodiesterase (Tdp1) catalyzes the
envelope proteins [12–14]. The N-terminal regions ofhydrolysis of a phosphodiester bond between a tyro-
these proteins are poorly conserved, and, indeed, thesine residue and a DNA 3 phosphate. The enzyme
first 148 amino acids of human Tdp1 can be removedappears to be responsible for repairing the unique
without an effect on catalysis in vitro [11]. With the ex-protein-DNA linkage that occurs when eukaryotic to-
ception of the poxvirus proteins, which may lack enzy-poisomerase I becomes stalled on the DNA in the cell.
matic activity, all of the enzymes in the superfamily cata-The 1.69 A˚ crystal structure reveals that human Tdp1
lyze a phosphoryl transfer reaction where the acceptoris a monomer composed of two similar domains that
is either an alcohol or water. The similar reaction chemis-are related by a pseudo-2-fold axis of symmetry. Each
try for the members of the family appears to derive fromdomain contributes conserved histidine, lysine, and
a pair of motifs (referred to as HKD motifs), each ofasparagine residues to form a single active site. The
which contains a highly conserved histidine, lysine, andstructure of Tdp1 confirms that the protein has many
aspartate residue in the sequence HxK(x)4D [14]. Sincesimilarities to the members of the phospholipase D
the Tdp1 motifs contain the conserved histidine and(PLD) superfamily and indicates a similar catalytic
lysine residues but lack the aspartate residues, this en-mechanism. The structure also suggests how the un-
zyme represents a distinct class within the PLD super-usual protein-DNA substrate binds and provides in-
family [11]. It has been suggested, based on an analysissights about the nature of the substrate in vivo.
of reaction intermediates and products, that catalysis
proceeds with the formation of a phosphoenzyme inter-
Introduction mediate that is subsequently cleaved to form the final
product [15–17]. In two cases, a histidine in one of the
Tyrosyl-DNA phosphodiesterase (Tdp1) catalyzes the HKD motifs has been directly implicated as the nucleo-
hydrolysis of a phosphodiester bond between a tyrosine phile in the reaction leading to the covalent intermediate
residue and a DNA 3 phosphate [1]. The only known [18, 19]. Crystal structures of Nuc and a phospholipase
example of such a linkage in eukaryotic cells occurs in D reveal that the conserved active site histidine and
the enzyme-DNA covalent complex formed when a type lysine residues are clustered and bound to phosphate
IB DNA topoisomerase cleaves DNA. Therefore, it has or tungstate ligands in a way that is consistent with the
been suggested that Tdp1 is responsible for cleaving proposed chemistry [20, 21].
such complexes when they become stalled on the DNA The exact substrate for Tdp1 in the repair of topoisom-
in the cell [1]. Although there is little evidence for the erase I-DNA covalent complexes in vivo is uncertain,
formation of such complexes in vivo, there is abundant but a complex containing the native form of human topo-
in vitro evidence showing that a variety of conditions isomerase I is cleaved poorly, if at all, by human Tdp1
can prevent or slow religation by topoisomerase I and (H. Interthal and J. Champoux, unpublished data). This
therefore cause the trapping of the enzyme on the DNA. result is understandable in view of the structure of the
These conditions include DNA damage leading to the topoisomerase I-DNA covalent complex, where the ty-
generation of nicks, gaps, or abasic sites, the incorpora- rosyl-DNA phosphodiester bond is completely buried
tion of nucleotide analogs, such as Ara-C, or treatment within the complex [22]. Interestingly, a bacteriophage
with drugs, such as camptothecin, that poison the topo- Int protein-DNA complex (which also contains a 3 DNA
isomerase reaction (reviewed in [2–4]). The cytocidal
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Table 1. Data Collection and Refinement Statistics
Peak Inflection Remote
Data Collection
 (A˚) 0.9792 0.9794 0.9640
Space group P21212 P21212 P21212
Unit cell dimensions, a, b, c (A˚) 52.03, 56.31, 186.45 52.11, 56.36, 186.60 52.17, 56.39, 186.71
Resolution (A˚) 1.69 1.69 1.69
Mosaicity () 0.238 0.281 0.329
Unique reflections 59,625 59,162 57,856
Completeness (highest shell; %) 96.0 (76.4) 95.2 (72.9) 93.1 (66.2)
Average I/a 13.42 16.06 18.80
Redundancy 4.48 3.58 3.33
Rsym (%)b 6.3 (19.2) 4.8 (23.4) 5.1 (42.4)
Figure of merit 0.540
Refinement
Resolution range (A˚) 30.0–1.69
Reflections (free) 66,989 (3,349)
Rcrystal/Rfree (%)c 19.8/22.9
Rms deviations from ideality
Bond lengths (A˚) 0.018
Bond angles () 1.813
Chirality 0.137
a I/ is the mean reflection intensity divided by the estimated error.
b Rsym  (|Ihkl  I	|)/(Ihkl), where the average intensity I	 is taken over all symmetry equivalent measurements and Ihkl is the measured
intensity for any given reflection.
c Rcrystal  ||Fo|  |Fc||/|Fo|, where Fo and Fc are the observed and calculated structure factor amplitudes, respectively. Rfree is equivalent to Rcrystal,
but calculated for 5% of the reflections chosen at random and omitted from the refinement process.
phosphotyrosine linkage) is poorly cleaved by Sacchar- struct also contains a 25-residue N-terminal tag that
includes a (His)6 affinity sequence, a linker, and a throm-omyces cerevisiae Tdp1; however, prior heating of the
Int-DNA complex to 65C greatly increased cleavage by bin cleavage site. Although this affinity tag is intact in
the crystallized protein, only four residues at the C-ter-the enzyme [1]. These observations suggest that the
initial topoisomerase I-DNA covalent complex must be minal end of the tag are visible in the electron density
map and are designated as Glu145–Pro148. The struc-processed in some way to make the tyrosine-DNA phos-
phodiester bond accessible to Tdp1 [1]. ture includes a cis-prolyl peptide bond between Leu576
and Pro577. Evaluation of the model with PROCHECKHere, we present the crystal structure of a fully active
N-terminal truncation of human Tdp1 protein that is [23] shows that 89.5% of the residues lie in the most
favored regions of the Ramachandran plot, 9.7% in themissing the first 148 amino acids. The crystal structure
firmly establishes the relationship with members of the additionally allowed regions, 0.8% in the generously al-
lowed regions, and none in the disallowed regions.PLD superfamily and provides important insights into
the chemistry of catalysis. Moreover, our structure sug- The Tdp1 structure (Figures 2A and 2B) contains 11

 helices and 17  strands as identified by DSSP [24].gests how this unusual enzyme may interact with its
protein-DNA substrate. For simplicity, the designations of DSSP were modified
so that 
 turns that included only a single hydrogen
bond were not classified as numbered 
-helical seg-Results and Discussion
ments. The tertiary structure can be described as an

--
--
 sandwich composed of two 
--
 domainsDescription of Human Tdp1 1148 Structure
that are related by a pseudo-2-fold axis of symmetry.The crystal structure of human Tdp1 was solved by
The N-terminal domain extends from Gly149 to Thr350multiwavelength anomalous dispersion methods from
(Figure 2, blue), and the C-terminal domain runs fromselenomethionine-labeled protein. The 1.69 A˚ structure
Asn351 to Ser608 (Figure 2, yellow). Each domain hashas a crystallographic R factor of 19.8% and an Rfree
in common a seven-stranded mixed parallel-antiparallelof 22.9%. Data collection, processing, and structural
 sheet and two conserved 
 helices (
1 and 
2 ofrefinement statistics are listed in Table 1, and a repre-
the N-terminal domain correspond to 
6 and 
7 of thesentative view of the electron density map is shown
C-terminal domain, respectively). The directionality andin Figure 1. The protein construct was an N-terminal
position of the  strands are conserved between thetruncation of human Tdp1 missing the first 148 amino
two seven-stranded sheets. Each domain contains oneacid residues that retained full catalytic activity [11].
of the conserved HKD sequence motifs. A superpositionUsing the numbering system of the full-length protein,
of the two domains (Figure 2C) reveals an rms differencethe three-dimensional model extends from residue
for 111 conserved 
 carbons between the two domainsGly149 to the C terminus of human Tdp1 (Ser608), with
of 5.20 A˚, with sequence identity of 10.0%. Beyond thisthree disordered loops between His382 and Ser391,
Gly424 and Val435, and Lys555 and Ala568. The con- nearly symmetrical scaffold, however, several differ-
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(including four residues of the affinity tag linker) pro-
trudes from one side of the globular protein, in a confor-
mation that is stabilized by crystal-packing interactions
with a neighboring Tdp1 monomer. The C-terminal do-
main is 60 residues larger than the N-terminal domain.
Four 
 helices that are not present in the N-terminal
domain (
8, 
9, 
10, and 
11), an additional  sheet
consisting of three short antiparallel strands (9, 15,
and 16), and an extended coil at the C terminus contrib-
ute to the larger size. The variations in secondary struc-
ture elements and loops that surround the symmetrical
core of Tdp1 create a highly asymmetric molecular
surface.
The active site region containing the pairs of highly
conserved histidine and lysine residues of the HKD mo-
tifs of the PLD superfamily is centered at the pseudo-
2-fold axis of symmetry between the two domains, at a
point where the convex sides of the large  sheets from
each domain come in closest contact with one another.
The active site residues lie near the middle of an elon-
gated cleft that runs along one entire surface of the
protein. Loops 4-5 and 12-13 contribute the key
histidine and lysine residues of the HKD motifs that have
been shown by mutagenesis studies to be important
for catalysis: His263, Lys265, His493, and Lys495 [11]
(Figure 2B). Four additional residues that are conserved
in all Tdp1 orthologs, Asn283, Gln294, Asn516, and
Glu538, are also located in the active site. Asn283 and
Gln294 are present on loop 6-7, Asn516 is found on
loop 14-
11, and Glu538 is in strand 17. The possible
role of some of these active site residues in catalysis
will be discussed below.
The constellation of residues in the active site retains
the symmetry of the overall tertiary structure, with each
domain contributing a histidine, lysine, and asparagine
residue (Figure 3). In each domain, the N of an active
site lysine is within hydrogen bonding distance of the
backbone carbonyl oxygen of the histidine residue from
the same domain. The conserved asparagine residues
Asn283 and Asn516 are symmetrically oriented toward
the center of the active site, and each interacts with a
water molecule in the active site via hydrogen bonds to
N2. The symmetry of the active site is broken by the
nature of two residues that interact with the active site
histidines. The N1 atom of His263 on the N-terminal
domain is within hydrogen bonding distance of a car-
boxyl oxygen of Glu538 from the C-terminal domain,
which is in turn within hydrogen bonding distance of O
of Ser514. The backbone carbonyl oxygen of Ser514 is
also within hydrogen bonding distance of N1 of His263,
completing a hydrogen bonding circuit between the
Figure 1. Electron Density Associated with a Cluster of Tyrosine three residues. A similar hydrogen bonding pattern is
Residues in the C-terminal Domain of Tdp1 found on the other domain related by the pseudo-2-
(A) The initial electron density map calculated by SOLVE [32]. fold axis of symmetry, except that His493 interacts with
(B) The solvent-flattened electron density output from Resolve [33]. glutamine (Gln294) and threonine (Thr281) residues in-
(C) The final A-weighted 2Fo  Fc map calculated by Refmac5 [27]. stead of with glutamic acid and serine. Another asymme-
In all cases, the maps are contoured at 1.5 . Figures 1, 2, 6, 7, and
try in the active site can be found in the arrangement8 were generated with the program Ribbons [37].
of two water molecules (designated Wat1 and Wat2)
that are well ordered in the electron density map.
ences distinguish the two domains of Tdp1. The N-ter- Whereas Wat1 is within hydrogen bonding distance of
minal domain has three 
-helical segments that are not N2 of Asn283, N2 of His263, and N2 of His493, Wat2
found in the C-terminal domain (
3, 
4, and 
5). A coil is positioned within hydrogen bonding distance of N
of Lys495, N2 of Asn516, N2 of His263, and N2 ofconsisting of eight N-terminal residues of Tdp1 1–148
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Figure 2. Ribbon Representations of the Struc-
ture of Human Tdp1
(A) Stereoview of Tdp1 colored to show the
two-domain structure of the protein. The
N-terminal domain of Tdp1 (residues 149–
350) is colored blue, and the C-terminal do-
main (residues 351–608) is colored yellow.
The view is perpendicular to the pseudo-2-
fold axis of symmetry between the two do-
mains. The active site residues His263,
Lys265, His493, and Lys495 are depicted as
red ball and stick structures.
(B) Same as (A), rotated to view the molecule
parallel to the pseudo-2-fold axis of sym-
metry.
(C) Superposition of the two domains of Tdp1.
Coloration is the same as in (A) and (B), ex-
cept that the active site residues have the
same coloration as their respective domains.
His493. Thus, the overall arrangement of the active site is on the opposite side of the molecule. As may be ex-
pected for an enzyme that hydrolyzes protein-DNA co-pseudosymmetrical, with the two key histidine residues
existing in distinctly different chemical environments. valent complexes, the substrate binding cleft is asym-
metrical in terms of both shape and charge distributionThe active site lies at the bottom and near the center
of an approximately 40 A˚-long cleft that runs along the (Figure 4). On one side of the active site, the cleft is
relatively narrow and lined with predominantly positivelyentire “top” surface of Tdp1, nearly perpendicular to the
domain-domain boundary (Figures 2B and 4). The shape charged amino acid residues. On the other side of the
active site, the cleft has a greater negative charge distri-of this substrate binding cleft is well defined, as all three
of the disordered loops in the Tdp1 structure are located bution and flares out into a more open, bowl-shaped
Structure of Human Tyrosyl-DNA Phosphodiesterase
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active site histidine residue from the other domain func-
tions as a general acid, donating a proton to the leaving
group. The formation of a covalent intermediate has
been shown for several members of the PLD superfam-
ily, including human Tdp1 [11, 18, 19, 25]. In the cases
of Nuc and the bacterial toxin, the intermediate has been
shown to involve a linkage to one of the active site
histidines. In the second step of the proposed catalytic
reaction, the other active site histidine may act as a
general base to activate a water molecule that subse-
quently hydrolyzes the phosphoenzyme intermediate.
In the structure of Tdp1, the N1 atom of the catalytic
histidine from the N-terminal domain, His263, is within
hydrogen bonding distance of one of the side chain
oxygens of the conserved acidic residue, Glu538, from
the C-terminal domain. This arrangement is roughly
maintained on the other side of the active site, except
that the active site histidine residue from the C-terminal
domain, His493, is hydrogen bonded to the O1 atom
of a glutamine residue, Gln294. These interactions would
be expected to stabilize the N1-H tautomer of both
Figure 3. Schematic View of the Hydrogen Bonding Pattern Ob- active site histidines, leaving the substrate proximal N2
served in the Active Site of Tdp1
atoms of both histidines as possible candidates for the
Bonds of residues from the N-terminal domain of Tdp1 are colored nucleophile in the first step of the reaction. However,
blue, and residues from the C-terminal domain are colored yellow.
His263 is in close contact with a negatively chargedThis view was created with the program LIGPLOT [38].
residue, whereas His493 is in a more neutral environ-
ment. This asymmetry suggests that His263, rather than
His493, is the nucleophile, since the negatively chargedbasin. The shape and surface charge of the substrate
side chain of Glu538 would be expected to stabilizebinding cleft suggest that the narrow, positively charged
the developing positive charge on the imidazole ringside may act as a DNA binding region, while the more
of His263 during the formation of the phosphohistidineopen side with the more negative charge distribution
intermediate. In addition, the negative glutamate sideis better suited to binding the protein moiety of the
chain could enhance the nucleophilicity of His263 N2substrate. The dimensions of the putative DNA binding
for attack on the phosphorus atom of the substrate.side of the substrate binding cleft may provide clues to
That His263 is the nucleophile in the first step of thethe general mode of DNA binding by the enzyme: the
reaction is supported by the finding that the H263A mu-cleft is narrow (approximately 8–10 A˚ wide) and deep
tant has virtually no catalytic activity and does not form(10–15 A˚), with the deepest and narrowest portions di-
a covalent intermediate [11].rectly above the active site. This portion of the cleft
Mutation of the conserved lysine residues of PLD su-could accommodate a single strand of DNA but is too
perfamily members impairs their catalytic activity [11,narrow to accommodate a DNA duplex without a confor-
18, 19, 20, 25, 26], and it has been proposed that thesemational change. In addition to having a predominantly
residues are involved in binding to the phosphate moietypositively charged cleft, the surface of the Tdp1 protein
of substrate and neutralizing its negative charge [20,on the putative DNA binding side of the cleft also has
21]. It is also likely that the conserved lysine residuesa predominately positive charge (Figure 4) and may be
may play a key role in transition state stabilization. Thesuited for nonspecific binding of DNA.
conserved asparagine residues interact with well-The putative protein binding side of the cleft is much
ordered water molecules in the active site and may alsolarger and roughly bowl shaped, flaring from a width of
be involved in substrate binding. In conclusion, it seems8 A˚ directly above the active site to a width of roughly
that Tdp1 essentially follows the previously proposed20 A˚. The walls of this cleft extend approximately 15 A˚
catalytic mechanism for PLD superfamily members;above the deepest part of the cleft. Although this side
however, Tdp1 is unique among the PLD superfamilyof the substrate binding cleft is too small to accommo-
members with known structure, in that it possesses adate an intact molecule of topoisomerase I, it could
chemically asymmetrical active site, which suggestseasily accommodate a molecule larger than a single
that His263 acts as the nucleophile in the first step oftyrosine residue or a short peptide (see below).
the reaction.
Catalytic Mechanism of Tdp1
In the two-step catalytic mechanism for the enzymes in Comparison to Other Enzymes
in the PLD Superfamilythe PLD superfamily outlined by Stuckey and Dixon [20],
an active site histidine residue from one domain acts As mentioned earlier, comparison of active site compo-
sition and conservation of sequence motifs have shownas a nucleophile that attacks the substrate phosphorous
atom and cleaves the phosphodiester linkage, resulting Tdp1 to belong to the PLD superfamily [11]. The three-
dimensional crystal structures of two PLD family mem-in the formation of a phosphoenzyme intermediate. The
Structure
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Figure 4. Three Stereoviews of the Electro-
static Potential Surface of Tdp1
Each view was generated with the program
GRASP [39]. Electrostatic surfaces are col-
ored between10 kT (red) and10 kT (blue).
Each view is rotated 90 away from the orien-
tation in the adjoining section of the figure.
(Top) View along the substrate binding cleft
from the putative protein binding side. The
cleft is located at the top of the molecule in
this orientation.
(Middle) View parallel to the pseudo-2-fold
axis of symmetry between the two domains
of Tdp1 (this orientation is identical to that of
the ribbon diagram in Figure 2B). The location
of the active site is marked with a yellow as-
terisk.
(Bottom) View along the substrate binding
cleft from the putative DNA binding side. The
cleft is located at the bottom of the molecule
in this orientation.
bers, a bacterial nuclease from Salmonella typhimurium proximate positions of five 
 helices are also conserved
between the three structures.(Nuc) and a PLD from Streptomyces sp. PMF have pre-
viously been solved [20, 21]. Despite very low sequence As noted above, human Tdp1 and its orthologs form
a distinct class within the PLD superfamily, becauseidentity outside of the conserved active site residues,
the overall structures of Streptomyces PLD and Nuc they lack the conserved aspartate residue of the HKD
sequence motif. The crystal structures of Nuc and Strep-have many similarities with Tdp1 (Figures 5 and 6). Like
Tdp1, Streptomyces PLD is a two-domain structure, with tomyces PLD show that the conserved aspartate residue
does not participate in catalysis, since it is located someeach domain consisting of a  sheet surrounded by 

helices, while Nuc is a homodimer, with each subunit 19 A˚ away from center of the active site of the enzyme.
In Nuc, this residue lies on a turn between 5 and 6corresponding to one domain of Tdp1 or Streptomyces
PLD. The major  sheet in each domain of Tdp1 consists and is positioned to form four hydrogen bonds with a
tight turn between 
1 and 2. The corresponding aspar-of seven strands each, whereas the sheets in Nuc con-
sist of eight strands, and Streptomyces PLD contains tate residues on both domains of Streptomyces PLD
are involved in similar interactions and are thought toone sheet of eight strands and one sheet of nine strands.
In each case, however, the first seven  strands have be important for stabilization of the tertiary structure of
the molecule [21]. In Tdp1, the amino acid positionsthe same topology, 1765234, with strands 2, 3, and 4
parallel and the rest antiparallel. The topology and ap- corresponding to the conserved aspartate in Streptomy-
Structure of Human Tyrosyl-DNA Phosphodiesterase
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Figure 5. Structure-Based Sequence Alignment and Secondary Structure Comparison for Human Tdp1, Phospholipase D, and Bacterial
Nuclease
Alignment is based on regions of three-dimensional overlap between the crystal structures of Tdp1 (Tdp, red), phospholipase (PLD, green;
RCSB accession number 1F0I) and bacterial nuclease (Nuc, purple; RCSB accession number 1BYS). Large stretches of PLD and Nuc sequence
that do not overlap with Tdp1 have been omitted, and a double slash (//) marks the boundary between the two monomers of Nuc. Areas of
sequence identity are marked with red text, and the conserved His, Lys, Asn, and acidic residues of the catalytic active sites of these enzymes
are boxed and highlighted in gold.
ces PLD and Nuc are buried in the hydrophobic core of with an rms difference of 2.57 A˚. When Tdp1 is superim-
posed on a dimer of Nuc, 156 C
 atoms overlap, withthe molecule, because the  strands in the sheets are
longer than those in Streptomyces PLD and Nuc. In the an overall rms difference of 3.13 A˚. The overlapping
residues of Tdp1 and Streptomyces PLD share onlyN-terminal domain of Tdp1, there is a glutamic acid
residue that resides on the loop between 5 and 6, but 12.1% sequence identity, whereas the overlapping resi-
dues of Tdp1 and Nuc share 17.3% sequence identity.it only has two potential hydrogen bonding interactions
with the loop between 
1 and 2. Overall, it appears Although the three enzymes share very low sequence
identity overall, the active site residues superimposethat the tight, aspartate-stabilized turns found in Strep-
tomyces PLD and Nuc are not necessary for the struc- remarkably well. Figure 7 shows the three-dimensional
alignment of the active site residues of Tdp1, Streptomy-tural stability of Tdp1.
Structural overlaps between Tdp1 and Streptomyces ces PLD, and Nuc. It is striking that the overall side
chain conformations are very similar, even though Tdp1PLD and Nuc were created with the program LSQKAB
[27]. Between Tdp1 and the PLD, 173 C
 atoms overlap, was solved in the absence of substrate or substrate
Structure
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occupied by two oxygen atoms of the tungstate and
phosphate ligands in Nuc and Streptomyces PLD. The
major difference in side chain conformations between
the three structures is that the catalytic histidine on
the N-terminal domain of Streptomyces PLD is rotated
approximately 90 about 1 relative to the conformations
found in Nuc and Tdp1, such that N1, not N2, is within
hydrogen bonding distance of the phosphate. Interest-
ingly, Leiros et al. [21] reported that in a tungstate-bound
structure of Streptomyces PLD, the histidine on the
N-terminal domain adopts a conformation similar to that
found in Nuc, with the N2 atom of the residue oriented
toward the tungstate. The tungstate ion in this unpub-
lished Streptomyces PLD structure was reported to be
closer to the histidine on the N-terminal domain than to
the histidine on the C-terminal domain. The authors cited
this finding as evidence suggesting that the N-terminal
histidine residue may be the more probable nucleophile
in the catalytic mechanism. Such a finding is consistent
with the suggestion, based on our structure above, that
the N-terminal domain of Tdp1 contains the nucleophilic
histidine. Interestingly, experimental evidence from
Streptomyces antibioticus has indicated that the active
nucleophile resides on the C-terminal domain for that
particular enzyme [25].
Structural Clues to the Nature
of the Tdp1 Substrate
Tdp1 has been implicated as a specific repair enzyme
for topoisomerase I-DNA lesions, but it is not likely to
act on the intact protein-DNA complex. The covalent
human topoisomerase I-DNA complex consists of a 91
kDa protein linked to the DNA via a 3 tyrosyl phospho-
diester bond buried deep within the complex [22]. It
seems apparent, a priori, that the substrate of Tdp1
cannot become accessible to the enzyme without some
alteration of the topoisomerase-DNA complex. Yang et
Figure 6. Three-Dimensional Structural Comparison of Tdp1, PLD, al. [1] proposed that denaturation and/or proteolysis of
and Nuc
the topoisomerase, through some unknown mechanism,
Ribbon representations of PLD (top), Tdp1 (middle), and bacterial
might be a necessary precursor to hydrolysis of the 3nuclease (Nuc, bottom), are all shown in the same orientation,
phosphodiester bond. Recent evidence has indicatedviewed perpendicular to the 2-fold (or pseudo-2-fold) axis of symme-
that repair of lesions by Tdp1 occurs only after double-try between the two domains of the protein. The orientation of Tdp1
in this figure is the same as that in Figure 2A but rotated 90 counter strand break formation resulting from collision of a repli-
clockwise in the plane of the paper. Coloration of the models high- cation fork with a topoisomerase-DNA complex [28].
lights regions of structurally conserved secondary structure ele- Thus, both the DNA and the protein moieties of the Tdp1
ments. For Tdp1, these conserved elements are: 1 and 8 (dark
substrate appear to undergo some form of degradationblue); 2, 3, 4, 10, 11, and 12 (yellow); 
1, 
2, and 
3 (green);
and processing before Tdp1 can separate them. The
4 (blue); 5 and 13 (orange); 6 and 14 (red); 7 and 17 (purple);
exact nature of the Tdp1 substrate is still unknown, but
7 (cyan). Loops and regions of secondary structure that are not
conserved among all three structures are colored gray. Ball and the structure of the Tdp1 protein helps provide some
stick representations in the PLD and Nuc structures indicate the important clues that limit the range of possibilities.
positions of phosphate and tungstate ions, respectively, and mark Recent studies have shown that the cleavage effi-
the location of the active sites.
ciency of S. cerevisiae Tdp1 is dependent on the struc-
ture of the attached DNA [28]. These studies showed
that, whereas yeast Tdp1 did not efficiently cleave sub-fragments, whereas the Streptomyces PLD and Nuc
structures contain phosphate and tungstate ions, re- strates with 3 tyrosyl phosphodiester bonds in the mid-
dle of a nicked duplex, very little preference was shownspectively. Although PLD, Nuc, and Tdp1 act on dis-
tinctly different substrates, the substrates for all three between substrates that were single stranded, blunt
ended and double stranded, or double stranded with aenzymes have in common a phosphodiester moiety.
Each enzyme is expected to bind phosphate at the cen- 5 tail. These results are somewhat difficult to rationalize
in light of the structure of the human Tdp1 substrateter of the active site, in presumably similar orientations.
Interestingly, the oxygens of the two water molecules binding cleft. As described above, the putative DNA
binding cleft in the human Tdp1 structure is only widein the Tdp1 active site occupy positions close to those
Structure of Human Tyrosyl-DNA Phosphodiesterase
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Figure 7. Comparison of the Active Sites of
Tdp1, PLD, and Nuc
Tdp1 is depicted as a ribbon structure with
the same coloration as in Figure 2. The active
site residues of Tdp1 are shown as ball and
stick structures with red-colored bonds. The
active site residues from PLD are shown as
green stick structures, and the active site res-
idues from Nuc are shown as violet stick
structures. Similarly, the phosphate group in
the active site of PLD is shown in green, and
the tungstate ion present in the structure of
Nuc is shown in violet. Two water molecules
found in the active site of Tdp1 are depicted
as red spheres.
enough to accommodate a single strand of DNA. Two no clashes between the two proteins. In support of this
model, a substrate consisting of single-stranded DNApossible mechanisms can be envisioned for cleavage
of a substrate involving a double-stranded DNA moiety. covalently bound to the 6.3 kDa C-terminal domain of
human topoisomerase I has been shown to be a suitableOne possibility is that only single-stranded DNA can
bind near the active site of DNA, and that melting of the substrate for human Tdp1 (H. Interthal and J. Champoux,
unpublished data). These experiments suggest that thefirst few base pairs of the duplex must occur prior to
binding of the phosphotyrosine in the active site of Tdp1. protein moiety of the natural Tdp1 substrate could be
as large as the C-terminal domain of human topoisomer-If unpairing of the DNA occurs prior to or during binding,
the positive electrostatic potential on the face of the ase I. These structural considerations will certainly be
informative in future attempts to define the Tdp1 sub-putative DNA binding side of Tdp1 may help by binding
the DNA of the complementary strand. Another possibil- strate in vivo.
ity is that a conformational change takes place in Tdp1
that widens the DNA binding cleft to accommodate dou- Biological Implications
ble-stranded DNA.
The exact nature of the protein moiety of the Tdp1 When eukaryotic topoisomerase I becomes stalled on
the DNA in the cell, the resulting lesion consists of asubstrate is another open question. Since full-length
topoisomerase I-DNA complexes are apparently not phosphodiester bond between a tyrosine residue and
a DNA 3 phosphate. This unique linkage can occurcleaved by human Tdp1 (H. Interthal and J. Champoux,
unpublished data), many in vitro studies have employed as a result of various forms of DNA damage or from
treatment with anticancer drugs, such as camptothecin,minimal protein moieties, such as a single tyrosine resi-
due in the case of S. cerevisiae Tdp1 [1, 28, 29] or a and tyrosyl-DNA phosphodiesterase (Tdp1) has been
implicated in the repair of such lesions in vivo [1, 28].relatively short peptide in the case of human Tdp1 [11].
However, the broad area of the putative protein binding Since the activity of Tdp1 can theoretically counteract
the effects of camptothecin, drugs that inhibit Tdp1cleft suggests that a much larger protein moiety could
bind to Tdp1. Inspired by the shape of the putative could potentially act synergistically with topoisomerase
poisons in combined drug therapy regimens. Elucidationprotein binding region of the Tdp1 substrate binding
cleft, modeling studies were carried out in which the of the structure of Tdp1 is an important step in any such
inhibitor design effort.6.3 kDa C-terminal domain of topoisomerase I (which
contains the catalytic tyrosine residue) was manually The overall tertiary structure of human Tdp1 is strik-
ingly similar to the known structures of two phospholi-docked into the putative protein binding cleft of Tdp1
(Figure 8). For the creation of this model, the C-terminal pase D (PLD) superfamily members, a Streptomyces
PLD [21] and a bacterial nuclease (Nuc) [20]. The protein46 residues from the crystal structure of human topo-
isomerase I in covalent complex with DNA were used is an 
--
--
 sandwich composed of two 
--
 do-
mains that are related by a pseudo-2-fold axis of sym-(Protein Data Bank accession number 1A31) [22]. The
phosphate moiety of the phosphotyrosine residue was metry. Each domain contributes conserved histidine,
lysine, and asparagine residues to form a single activepositioned in the active site of Tdp1 so that the phos-
phate overlapped with the tungstate binding site of the site. Unlike the active sites of PLD and Nuc, the two
active site histidines of Tdp1 exist in distinct chemicalanalogous Nuc structure. The phosphate group was
held static while the rest of the C-terminal domain was environments, with the histidine residue on the N-ter-
minal domain being the probable nucleophile for therotated to find an optimal fit in the binding cleft of Tdp1.
The resultant model displays a good complementary fit cleavage step of the reaction.
The scissile phosphodiester bond in a topoisomerasebetween the topoisomerase fragment and Tdp1, with
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Figure 8. Two Stereoviews of a Hypothetical
Model of the Human Topoisomerase I C-ter-
minal Domain Docked into the Putative Pep-
tide Binding Cleft of Tdp1
The molecular surface of Tdp1 is depicted in
purple. The red ribbon structure represents
the C-terminal domain of human topoisomer-
ase I from residue 720 to 765, and the phos-
photyrosine residue (Tyr723) is depicted as
a cyan ball and stick structure. The yellow
spheres on the other side of the substrate
binding cleft represent the possible location
of a single strand of DNA that would be cova-
lently attached to the phosphotyrosine. The
top stereo pair shows a view of the model
roughly parallel to the pseudo-2-fold axis of
symmetry of Tdp1, and the orientation is es-
sentially the same as that in Figure 2b and
the middle of Figure 4. The bottom stereo pair
shows the model from the putative protein
binding side of the cleft, and the orientation
is the same as that in the top of Figure 4.
54.2 A˚, and c  50.0 A˚), although the monoclinic form appearedI-DNA linkage is buried deep within the complex. Several
primarily under higher concentrations of PEG and spermine. Dozenslines of evidence suggest that both the protein and DNA
of crystals appeared in each drop in less than 24 hr and usuallymoieties of the complex undergo some sort of pro-
reached full size in less than 4 days. Typical orthorhombic crystals
cessing and degradation before Tdp1 can separate reached sizes of 0.2  0.2  0.3 mm, and monoclinic crystals were
them [1, 28]. The structure of Tdp1 provides several usually 0.01 0.15 0.4 mm in size. Both crystal forms diffracted to
2.8 A˚ or better in house and between 1.5 A˚ and 2.0 A˚ with synchrotronclues to the nature of the substrate in vivo. Tdp1 has
radiation. To prepare monoclinic crystals for flash cooling, they werean asymmetrical, elongated substrate binding cleft that
transferred to a cryoprotectant containing 25% glycerol, 15% PEGappears well suited to binding a protein moiety on one
8000, 300 mM NaCl, 10 mM spermine, 100 mM CHES (pH 9.6), 1
side of the cleft and the DNA on the other. The structure mM EDTA, and 2 mM TCEP. The same cryoprotectant was used for
suggests that a protein moiety at least as large as the the orthorhombic crystal form; however, the orthorhombic crystals
6.3 kDa C-terminal domain of human topoisomerase I were much more sensitive to mechanical shock and cracked if trans-
ferred from crystallization drops to cryoprotectant solutions. Hence,may be accommodated by the protein binding side of
orthorhombic crystals were instead prepared for flash cooling bythe cleft but that only a single strand of DNA could
adding relatively large volumes of cryoprotectant directly to crystalli-be accommodated on the DNA binding side without a
zation drops. Next, orthorhombic crystals were immediately re-
conformational rearrangement. moved from drops and frozen by plunging directly into liquid ni-
trogen.
Experimental Procedures Selenomethionine derivatives were prepared by expressing Tdp1
1148 in a nonauxotrophic E. coli strain in M9 minimal media
Crystallization, Selenomethionine Derivatives, Freezing supplemented with selenomethionine and other amino acids (100
Conditions, and Data Collection mg each of Lys, Thr, and Phe and 50 mg each of Val, Leu, Ile, and
Human Tdp1 1148 was expressed and purified as previously SeMet per liter of culture) in order to suppress de novo methionine
described [11]. Purified protein was dialyzed into a buffer containing biosynthesis as described by Van Duyne, et al. [30]. Purification and
250 mM NaCl, 15 mM Tris (pH 8.2), 1 mM EDTA, and 2 mM Tris crystallization of selenomethionine-labeled protein was carried out
(2-carboxyethyl) phosphine (TCEP) and concentrated to 5–6 mg/ exactly as it was for unlabeled protein, except that 5 mM TCEP
mL. Tdp1 was crystallized by vapor diffusion in sitting drops by was present in all buffers to prevent oxidation of selenomethionine
combining equal volumes of protein solution and a crystallant con- residues. Electrospray ionization mass spectroscopy showed that
taining 11%–15% PEG 8000, 100 mM CHES (pH 9.6), and 2–15 mM the level of selenomethionine substitution was greater than 99%.
spermine. Two crystal forms were produced under these conditions, The SeMet data set was collected at the Advanced Light Source
a monoclinic form (P21; a  49.0 A˚, b  190.3 A˚, c  54.5 A˚, and beamline 5.0.2 with an ADSC Quantum 4 CCD detector. The data
were integrated, scanned, and reduced with the HKL software [31].  100.3) and an orthorhombic form (P21212; a  186.5 A˚, b 
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Phase Determination, Model Building, by drugs that trap covalent complexes between DNA topisomer-
ases and DNA. Mol. Pharmacol. 50, 1095–1102.and Structural Refinement
The structure of Tdp1 was determined using SOLVE version 1.18 11. Interthal, H., Pouliot, J.J., and Champoux, J.J. (2001). The ty-
rosyl-DNA phosphodiesterase Tdp1 is a member of the phos-[32] and three wavelengths of a MAD data set collected to 1.69 A˚
resolution. SOLVE found seven heavy-atom sites out of a possible pholipase D superfamily. Proc. Natl. Acad. Sci. USA 98, 12009–
12014.11 methionine residues present in the protein. Inspection of the final
model shows that 3 of the 11 methionine residues present in the 12. Koonin, E.V. (1996). A duplicated catalytic motif in a new super-
family of phosphohydrolases and phospholipid synthases thatprotein lie on disordered loops or in the disordered portion of the
His-tag and linker. Density modification of the original solution was includes poxvirus envelope proteins. Trends Biochem. Sci. 21,
242–243.carried out by RESOLVE version 1.05 [33]. These initial phases were
input into wARP/ARP [34] for automated model building and phase 13. Morris, A.J., Engebrecht, J., and Frohman, M.A. (1996). Structure
and regulation of phospholipase D. Trends Pharmacol. Sci. 17,improvement. wARP/ARP was able to trace the backbone and place
side chains for approximately 85% of the model of the protein. 182–185.
14. Ponting, C.P., and Kerr, I.D. (1996). A novel family of phospholi-Additional model building was carried out using XtalView [35]. Fur-
ther refinement was carried out using Refmac 5 [27, 36] and alternat- pase D homologues that includes phospholipid synthases and
putative endonucleases: identification of duplicated repeatsing cycles of manual rebuilding in XtalView.
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